Cargando…
ICU Complications of Hematopoietic Stem Cell Transplant, Including Graft vs Host Disease
Hematopoietic stem cell transplant (HSCT) is an essential treatment modality for many malignant and non-malignant hematologic diseases. Advances in HSCT techniques have dramatically decreased peri-transplant morbidity and mortality, but it remains a high-risk procedure, and a significant number of p...
Autor principal: | Stephens, R. Scott |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121823/ http://dx.doi.org/10.1007/978-3-030-26710-0_80 |
Ejemplares similares
-
Metabolic Targets for Improvement of Allogeneic Hematopoietic Stem Cell Transplantation and Graft-vs.-Host Disease
por: Tijaro-Ovalle, Natalia M., et al.
Publicado: (2019) -
2569. The Gut Microbiome and Acute Graft vs. Host Disease Risk in Hematopoietic Stem Cell Transplantation Recipients
por: Ilett, Emma E, et al.
Publicado: (2019) -
Assessing the yield and safety of endoscopy in acute graft-vs-host disease after hematopoietic stem cell transplant
por: Rajan, Anand V, et al.
Publicado: (2020) -
Adiponectin and resistin in acute and chronic graft-vs-host disease patients undergoing allogeneic hematopoietic stem cell transplantation
por: Robak, Oliver, et al.
Publicado: (2016) -
Gut microbiome in allogeneic hematopoietic stem cell transplantation and specific changes associated with acute graft vs host disease
por: Le Bastard, Quentin, et al.
Publicado: (2021)